iShares Edge MSCI Multifactor HlthC ETF (HCRF) is an exchange-traded fund that seeks to track the investment results of an index composed of U.S. large- and mid-capitalization stocks in the healthcare sector exhibiting favorable exposure to quality, value, size, and momentum factors. The fund provides investors with targeted exposure to healthcare companies selected based on multifactor criteria, including value and momentum characteristics of large-cap and mid-cap issuers; it operates within the broader asset management industry, focusing on equity ETFs for institutional and retail investors seeking factor-based strategies. Managed by BlackRock's iShares platform, headquartered in New York with global operations across the U.S., Europe, and Asia, the ETF launched as part of iShares' factor suite in the mid-2010s before its closure. In a major development, BlackRock announced the closure of HCRF in 2018 due to low assets under management and ongoing product reviews, with trading ceasing around August 22, 2018, and shareholders receiving cash distributions shortly thereafter; this aligned with the shuttering of several underperforming iShares Edge MSCI Multifactor ETFs, including the technology counterpart TCHF, reflecting strategic portfolio rationalization amid evolving client needs and market dynamics. The fund, listed on U.S. exchanges under ticker HCRF, catered primarily to U.S.-based investors targeting healthcare sector alpha through systematic multifactor selection rather than traditional market-cap weighting.